KDP Shorts Hit a Year High as Analysts Lift Targets Post-Earnings

Keurig Dr Pepper is carrying its highest short position in at least a year, with roughly 84.5 million shares sold short, equal to 6.2% of the free float, even as a cluster of analysts raised their price targets on the back of Q3 results reported November 3.

Short sellers added to their bets throughout the final week of October and into November. The position climbed 3.8% week-on-week and is now at its highest level in the 30-day window tracked, reversing a 7% decline seen through mid-to-late October when shorts had been covering. The jump in short interest is a reversal from the positioning captured in last week's earnings preview, which flagged 6.1% of float at the time. The position has crept higher since the print. Borrow costs remain low at 0.42%, down 3% on the week and 16% over the past month, so there is no tension in the lending market. Availability is ample at 751%, meaning roughly 7.5 shares remain available to borrow for every one already lent out. That is well below the 52-week tightest level of 570%, so conditions are loose. The options market, which was running at its most bullishly skewed level of the year going into Tuesday's earnings, has retraced sharply. The put/call ratio closed at 0.230 on November 3, still near its 52-week low of 0.223. The z-score has pulled back to minus 2.3 standard deviations below the 20-day mean, confirming that call-heavy positioning remains the dominant options posture even after the report.

The Street response to the Q3 print has been broadly constructive. Five analysts raised their price targets on November 4 alone. JP Morgan's Andrea Teixeira lifted her target to $41 while maintaining Overweight. Morgan Stanley's Dara Mohsenian went to $40 from $38, also Overweight. Wells Fargo moved to $40. TD Cowen and Evercore ISI raised targets but held more cautious ratings, Hold and In-Line respectively. The consensus target now sits at $37.0, against a close of $34.74 on November 3, a day on which the stock fell 5.6%. That gap between the direction of analyst revisions and the price action on the day of results is the central tension in the note right now. On the valuation side, the EV/EBITDA multiple has compressed to 8.7x, down roughly half a point over the past month, while the P/E of 13.9x has expanded nearly 1.5 points over the same period. The earnings yield factor ranks in the 58th percentile. The dividend score ranks in the 90th percentile, though dividend history data in the system is stale and predates 2023. The short score, an ORTEX composite reading, sits at 50.7, up from 46.9 a week ago, with the increase driven by the rebuild in short interest following the earnings release.

Retail attention has ticked up meaningfully. Wikipedia views and ORTEX page traffic together produce a z-score of 2.8 against the company's own trailing 90-day baseline, the highest reading in the dataset's recent window, as of October 19. That elevated attention coincides with the earnings event and the spinoff news that now sits at the centre of the structural story.

The structural story is the pending separation of the Global Coffee business. ORTEX forecasts a 60% chance of a share-count decrease across the Nasdaq-100, S&P 500, Russell 1000 and Russell 3000, all tied to the same event: the spinoff of Keurig's Global Coffee Co. unit. The estimated effective date is March 31, 2027, with an announcement expected around March 26. These are forecast dates, not confirmed by any index provider. No tracker-driven flow is expected ahead of the spinoff itself, the mechanical index impact, if any, would come at or after the transaction closes. JAB BevCo, the activist holder on the Schedule 13D register, has cut its disclosed stake from 9.9% to 4.4% as of a May 2025 filing. That reduction below the 5% reporting threshold means JAB may have continued selling without any obligation to file again, a point worth noting alongside the spinoff timeline given JAB's historical role as a key strategic backer of the coffee business.

The next earnings event is scheduled for November 5, one day after this note. What to watch is whether the gap between the post-results sell-off on November 3 and the direction of analyst target increases on November 4 narrows, and how the short position moves through the week given that borrow remains cheap and availability leaves room for further building.